Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 9
Submit an article Journal homepage
439
Views
3
CrossRef citations to date
0
Altmetric
Commentary

Lenalidomide in non-deletion 5q lower-risk myelodysplastic syndromes: a glass quarter full or three quarters empty?

Rory M. ShallisDepartment of Internal Medicine School of Medicine, Yale University, New Haven, USA;
&
Amer M. ZeidanDepartment of Internal Medicine School of Medicine, Yale University, New Haven, USA; ;Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, USACorrespondence[email protected]
Pages 2015-2017 | Received 08 Jan 2018, Accepted 15 Jan 2018, Published online: 07 Feb 2018

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Russell Lewis, Jan Philipp Bewersdorf & Amer M Zeidan. (2021) Clinical Management of Anemia in Patients with Myelodysplastic Syndromes: An Update on Emerging Therapeutic Options. Cancer Management and Research 13, pages 645-657.
Read now
Rory M. Shallis, Nikolai A. Podoltsev, Lohith Gowda, Amer M. Zeidan & Steven D. Gore. (2020) Cui bono? Finding the value of allogeneic stem cell transplantation for lower-risk myelodysplastic syndromes. Expert Review of Hematology 13:5, pages 447-460.
Read now
Rory M. Shallis, Jan Philipp Bewersdorf, Prajwal C. Boddu & Amer M. Zeidan. (2019) Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia. Expert Review of Anticancer Therapy 19:8, pages 717-729.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.